Specialty Pharmacy

Assured Pharmacy sales up 1.4%
BioMarin Pharmaceutical acquires ZyStor Therapeutics
FDA grants priority review for Bristol-Myer Squibb's skin cancer treatment
Jazz's Xyrem may treat fibromyalgia, FDA advisory committees say
Pfizer's Xyntha-administering syringe gets FDA approval

NEW YORK The Food and Drug Administration has approved a prefilled dual-chamber syringe made by Pfizer for treating hemophilia, Pfizer said.

The FDA approved the syringe for administering the drug Xyntha (antihemophilic factor [recombinant]) for hemophilia A. The drug is used to prevent and control bleeding episodes in patients.
Emergent acquires Trubion in near $100 million deal
PhRMA: Four states develop majority of mental illness treatments

WASHINGTON The companies working on more than half of the mental illness drugs under development are clustered in four U.S. states, according to research by the largest lobby for the drug industry.

The Pharmaceutical Research and Manufacturers of America compiled a study showing that of the 313 drugs, 192 are under development by companies in New York, New Jersey, North Carolina and California. The drugs are in clinical trials or under review by the Food and Drug Administration, PhRMA said.
FDA advisory committee recommends approval for ezogabine

Roche to acquire BioImagene